Records containing: Telogen Effluvium
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
-
CLINICAL_TRIALS study record update · 2026-03-27Efficacy and Safety of Millet Seed Extract in the Treatment of Telogen Effluvium in Female Patients: A Randomized, Double-Blind, Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-03-23Evaluation of the Efficacy and Safety of a Drinkable Nutraceutical in Improving Hair Loss in Patients Treated With GLP-1/GIP Receptor Agonists: a Double-blind, 1:1 Randomized, Placebo-controlled Study.
-
CLINICAL_TRIALS study record update · 2026-02-27Clinical Study to Evaluate the Efficacy and Safety of a Cosmetic Product in Subjects With Telogen Effluvium and Androgenic Alopecia
-
CLINICAL_TRIALS study record update · 2026-02-17Investigation of the Effect of Cosmetic Products Containing Latanoprost Acid on Hair Condition in Women Aged 18-60 Years
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-11Placebo-controlled, Parallel, Randomized (1:1), Double-blind Study Over 6 Months to Evaluate the Efficacy and Safety of the Food Supplement Olistic Women.
-
CLINICAL_TRIALS study record update · 2025-06-05Clinical Evaluation of the Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium : a Double-blind, Randomized, Placebo-controlled, Clinical Study
-
CLINICAL_TRIALS study record update · 2022-07-08Study Phase III, Randomized, Double-dummy, Placebo Controlled, Single-center, of Regarding the Non-inferiority of the Medication BL3000, When Compared to Pantogar® Treatment of Telogen Effluvium in Women.
-
CLINICAL_TRIALS study record update · 2022-06-09Evaluating PAI-1 Expression in the Hair Follicles of Patients With Non-scarring Hair Loss.
-
CLINICAL_TRIALS study record update · 2021-04-06COVID-19 Induced Telogen Effluvium
-
CLINICAL_TRIALS study record update · 2020-12-03Randomized, Comparative Study to Assess the Effects of Cosmetic Lotion on Telogen Effluvium in Women Compared to a Control Group
-
CLINICAL_TRIALS study record update · 2020-06-30Hair Regrowth Efficacy of Multi-Molecular Targeting Treatment (ALRV5XR), a Randomized Controlled Clinical Trial in Men With Androgenetic Alopecia, Telogen Effluvium or Self Reported Thinning Hair: THE HAIR REBOOT TRIAL - MEN
-
CLINICAL_TRIALS study record update · 2020-06-30Hair Regrowth Efficacy of Multi-Molecular Targeting Treatment (ALRV5XR), a Randomized Controlled Clinical Trial in Women With Androgenetic Alopecia, Telogen Effluvium or Self Reported Thinning Hair: THE HAIR REBOOT TRIAL - WOMEN
-
CLINICAL_TRIALS study record update · 2020-05-18Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women
-
CLINICAL_TRIALS study record update · 2017-09-06Controlled, Randomized, Double Blind Study, for the Evaluation of Tolerance and Trichological Efficacy of a Food Supplement: Bioscalin® New Formulation Versus Reference Formulation Currently on the Market and Placebo